REFERENCES
- Storm HH, Dickman PW, Engeland A, Haldorsen T, Hakulinen T. Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J 1999; 13: 430–5.
- Teppo L, Dickman PW, Hakulinen T, et al. Cancer patient survival-patterns, comparisons, trends-a population-based cancer registry study in Finland. Acta Oncol 1999; 38: 283–94.
- Sorenson S, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol 2001; 40: 327–39.
- G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation), Author A. Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. Tumori 1989; 75: 163–7.
- Mor V, Masterson-Allen S, Goldberg R, Guadagnoli E, Wool MS. Pre-diagnostic symptom recognition and help seeking among cancer patients. J Community Health 1990; 15:253–66.
- Kyriakos M, Webber B. Cancer of the lung in young men. J Thorac Cardiovasc Surg 1974; 67: 634–48.
- Billing JS, Wells FC. Delays in the diagnosis and surgical treatment of lung cancer [see comments]. Thorax 1996; 51: 903–6.
- Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petter-son G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 1997; 12: 880–4.
- O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000; 12: 141–4.
- Robinson E, Mohilever J, Zidan J, Sapir D. Delay in diagnosis of cancer. Possible effects on the stage of disease and survival. Cancer 1984; 54: 1454–60.
- Porta M, Gallen M, Malats N, Planas J. Influence of 'diagnostic delay' upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 1991; 45: 22 5–30.
- Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med 1986; 28: 746–50.
- Fontana RS. The Mayo Lung Project: a perspective. Cancer 2000; 89 (Suppl 11): 2352–5.
- Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86: 44–53.
- Tockman MS. Survival and mortality from lung cancer in a screened population: the Johns Hopkins Study. Chest 1986; 89 (Suppl): 324–35.
- Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990; 45: 26–33.
- Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening [see com-ments]. Chest 1993; 103 (Suppl 4): 337S–41.
- Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from base-line screening [see comments]. Lancet 1999; 354: 99–105.
- Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798–802.
- Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73: 1252–9.
- Heimann R, Hellman S. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 2000; 18: 591–9.
- Tubiana M, Koscielny S. Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res Treat 1991; 18: 125–40.
- Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 1997; 65: 284–97.
- Jung KJ, Lee KS, Kim H, et al. Ti lung cancer on CT: frequency of extrathoracic metastases. J Comput Assist To-mogr 2000; 24: 711–8.
- Menczer J, Krissi H, Chetrit A, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma [published erratum appears in Am J Obstet Gynecol 1996; 175: 1678]. Am J Obstet Gynecol 1955; 173: 774–8.
- Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Haller-man ET, Martini N. Detection of true pathologic stage I lung cancer in a screening program and the effect on survival. Cancer 1981; 47 (Suppl 5): 1182–7.
- Pemberton JH, Nagorney DM, Gilmore JC, Taylor WF, Bematz PE. Bronchogenic carcinoma in patients younger than 40 years. Ann Thorac Surg 1983; 36: 509–15.
- DeCaro L, Benfield JR. Lung cancer in young persons. J Thorac Cardiovasc Surg 1982; 83: 372–6.
- Mackillop WJ, Zhou Y, Quirt CF. A comparison of delays in the treatment of cancer with radiation in Canada and the United States [see comments]. Int J Radiat Oncol Biol Phys 1995; 32: 531–9.
- Mansson J, Bengtsson C. Pulmonary cancer from the general practitioner's point of view. Experience from the health centre area of Kungsbacka, Sweden. Scand J Prim Health Care 1994; 12: 39–43.
- Hartveit F. Time and place for sputum cytology in the diagnosis of lung cancer. Thorax 1981; 36: 299–302.
- Hackett TP, Cassem NH, Raker JW. Patient delay in cancer. N Engl J Med 1973; 289: 14–20.
- Antkowiak JG, Regal AM, Takita H. Bronchogenic carcinoma in patients under age 40. Ann Thorac Surg 1989; 47: 391–3.
- Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest 1992; 102: 1723–9.
- Dische S, Gibson D, Parmar M, Saunders MI. Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee. Thorax 1996; 51: 1262–5.